Human bactericidal/permeability-increasing protein and a recombinant NH2-terminal fragment cause killing of serum-resistant gram-negative bacteria in whole blood and inhibit tumor necrosis factor release induced by the bacteria.
Jerrold Weiss(New York University), Georgia Theofan(Response Technologies (United States))
Cited by 228
Related Papers
Competition between rBPI23, a recombinant fragment of bactericidal/permeability-increasing protein, and lipopolysaccharide (LPS)-binding protein for binding to LPS and gram-negative bacteria
|Infection and Immunity|1994|89
An amino-terminal fragment of human lipopolysaccharide-binding protein retains lipid A binding but not CD14-stimulatory activity.
|The Journal of Immunology|1994|84
Expression and Characterization of Cysteine-Modified Variants of an Amino-Terminal Fragment of Bactericidal/Permeability-Increasing Protein
|Protein Expression and Purification|1996|67
Biochemical Characterization of Recombinant Fusions of Lipopolysaccharide Binding Protein and Bactericidal/Permeability-increasing Protein
|Journal of Biological Chemistry|1997|62
The endotoxin-binding bactericidal/permeability-increasing protein (BPI): a target antigen of autoantibodies
|Journal of Leukocyte Biology|2001|48